Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 6, 2008 - Issue 9
Submit an article Journal homepage
377
Views
30
CrossRef citations to date
0
Altmetric
Clinical Trial Report

ARB candesartan and CCB amlodipine in hypertensive patients: the CASE-J trial

Toshio Ogihara Osaka General Medical Center, Osaka, Japan
,
Akira Fujimoto EBM Research Center, Kyoto University Graduate School of Medicine, Yoshida-konoecho, Sakyo-ku, Kyoto, 606-8507, Japan. [email protected]
,
Kazuwa Nakao EBM Research Center, Kyoto University Graduate School of Medicine, Yoshida-konoecho, Sakyo-ku, Kyoto, 606-8507, Japan; and, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan
&
Takao Saruta Keio University Graduate School of Medicine, Tokyo, Japan
Pages 1195-1201 | Published online: 10 Jan 2014

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Tian Shen, Jiwei Wang, Yingjun Yu & Jinming Yu. (2019) Comparison of real-world effectiveness between valsartan and non-RAS inhibitor monotherapy on the incidence of new diabetes in Chinese hypertensive patients: An electronic health recording system based study. Clinical and Experimental Hypertension 41:3, pages 244-254.
Read now
Juliana O Toledo, Clayton F Moraes, Vinícius C Souza, Audrey C Tonet-Furioso, Luís CC Afonso, Cláudio Córdova & Otávio T Nóbrega. (2015) Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α. Clinical Interventions in Aging 10, pages 209-215.
Read now
Roberto Ferrari & Eric Boersma. (2013) The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review. Expert Review of Cardiovascular Therapy 11:6, pages 705-717.
Read now
Massimo Volpe. (2012) Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan. Expert Review of Cardiovascular Therapy 10:8, pages 1061-1072.
Read now
Kanako Bokuda, Atsuhiro Ichihara, Mariyo Sakoda, Asako Mito, Kenichiro Kinouchi & Hiroshi Itoh. (2010) Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome. Vascular Health and Risk Management 6, pages 571-578.
Read now

Articles from other publishers (25)

Han Saem Jeong, Hong‐Seok Lim, Hun-Jun Park, Wang-Soo Lee, Jin-Oh Choi, Hui Seung Lee, Sang-Ho Jo & Soon Jun Hong. (2021) Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up. Scientific Reports 11:1.
Crossref
Atsuhito Saiki, Masahiro Ohira, Takashi Yamaguchi, Daiji Nagayama, Naomi Shimizu, Kohji Shirai & Ichiro Tatsuno. (2020) New Horizons of Arterial Stiffness Developed Using Cardio-Ankle Vascular Index (CAVI). Journal of Atherosclerosis and Thrombosis 27:8, pages 732-748.
Crossref
Que Wang, Xiaoxue Yu, Lin Dou, Xiuqing Huang, Kaiyi Zhu, Jun Guo, Mingjing Yan, Siming Wang, Yong Man, Weiqing Tang, Tao Shen & Jian Li. (2019) miR-154-5p Functions as an Important Regulator of Angiotensin II-Mediated Heart Remodeling. Oxidative Medicine and Cellular Longevity 2019, pages 1-16.
Crossref
E. V. Sayutina. (2018) Fixed combinations in modern hypertension treatment algorithms. Cardiovascular Therapy and Prevention 17:6, pages 86-94.
Crossref
Xiaodan lv, Yingshi Zhang, Yixuan Niu, Qi Song & Qingchun Zhao. (2018) Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus. Medicine 97:15, pages e0256.
Crossref
N. A. Dzhaiani. (2017) CANDESARTAN IN CARDIOLOGY PRACTICE. Medical Council:7, pages 12-16.
Crossref
Sandip Chaugai, Wen Yeng Meng & Amir Ali Sepehry. (2016) Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis. Journal of Cardiovascular Pharmacology and Therapeutics 21:4, pages 388-404.
Crossref
Sandip Chaugai, Lhamo Yanchang Sherpa, Amir A. Sepehry, Hisatomi Arima & Dao Wen Wang. (2016) Effect of RAAS blockers on adverse clinical outcomes in high CVD risk subjects with atrial fibrillation. Medicine 95:26, pages e4059.
Crossref
Atsuhito Saiki, Yuta Sato, Rena Watanabe, Yasuhiro Watanabe, Haruki Imamura, Takashi Yamaguchi, Noriko Ban, Hidetoshi Kawana, Ayako Nagumo, Daiji Nagayama, Masahiro Ohira, Kei Endo & Ichiro Tatsuno. (2016) The Role of a Novel Arterial Stiffness Parameter, Cardio-Ankle Vascular Index (CAVI), as a Surrogate Marker for Cardiovascular Diseases. Journal of Atherosclerosis and Thrombosis 23:2, pages 155-168.
Crossref
Toru Miyoshi & Hiroshi Ito. (2016) Assessment of Arterial Stiffness Using the Cardio-Ankle Vascular Index. Pulse 4:1, pages 11-23.
Crossref
Yi-Sheng Liou, Hung-Yi Chen, Lyun Tien, Yi-Sian Gu & Gwo-Ping Jong. (2015) Antihypertensive Drug Use and New-Onset Diabetes in Female Patients with Coronary Artery Disease. Medicine 94:36, pages e1495.
Crossref
Kozaburo Hayashi, Tomoyuki Yamamoto, Akira Takahara & Kohji Shirai. (2015) Clinical assessment of arterial stiffness with cardio-ankle vascular index. Journal of Hypertension 33:9, pages 1742-1757.
Crossref
Ling Wu, Song-Bai Deng & Qiang She. (2014) Calcium Channel Blocker Compared With Angiotensin Receptor Blocker for Patients With Hypertension: A Meta-Analysis of Randomized Controlled Trials. The Journal of Clinical Hypertension 16:11, pages 838-845.
Crossref
L P Hasvold, J Bodegård, M Thuresson, J Stålhammar, N Hammar, J Sundström, D Russell & S E Kjeldsen. (2014) Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients. Journal of Human Hypertension 28:11, pages 663-669.
Crossref
Viktor Viktorovich Fomin & Andrey Alekseevich Svistunov. (2013) Farmakologicheskaya blokada angiotenzinovykh retseptorov v lechenii arterial'noy gipertenzii: ot saralazina do sartanov. Systemic Hypertension 10:3, pages 43-48.
Crossref
Hiroshi Akazawa, Chizuru Yabumoto, Masamichi Yano, Yoko Kudo-Sakamoto & Issei Komuro. (2012) ARB and Cardioprotection. Cardiovascular Drugs and Therapy 27:2, pages 155-160.
Crossref
Ching-Ya Huang, Tsochiang Ma, Liyun Tien, Yow-Wen Hsieh, Shwu-Yi Lee, Hung-Yi Chen & Gwo-Ping Jong. (2013) A Retrospective Longitudinal Cohort Study of Antihypertensive Drug Use and New-Onset Diabetes in Taiwanese Patients. BioMed Research International 2013, pages 1-6.
Crossref
Li-Ya Yang, Xiao Ge, Yan-Li Wang, Kun-Ling Ma, Hong Liu, Xiao-Liang Zhang & Bi-Cheng Liu. (2013) Angiotensin Receptor Blockers Reduce Left Ventricular Hypertrophy in Dialysis Patients: A Meta-Analysis. The American Journal of the Medical Sciences 345:1, pages 1-9.
Crossref
L. C. van Vark, M. Bertrand, K. M. Akkerhuis, J. J. Brugts, K. Fox, J.-J. Mourad & E. Boersma. (2012) Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients. European Heart Journal 33:16, pages 2088-2097.
Crossref
V. Daien, Y. Duny, J. Ribstein, G. d. Cailar, A. Mimran, M. Villain, J. P. Daures & P. Fesler. (2012) Treatment of Hypertension With Renin-Angiotensin System Inhibitors and Renal Dysfunction: A Systematic Review and Meta-Analysis. American Journal of Hypertension 25:1, pages 126-132.
Crossref
Toshio Ogihara, Kenji Ueshima, Kazuwa Nakao, Kohshiro Fukiyama, Koji Oba, Shinji Yasuno, Akira Fujimoto, Tosiya Sato, Hiroaki Matsuoka & Takao Saruta. (2011) Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex). Hypertension Research 34:12, pages 1295-1301.
Crossref
Kenji Ueshima. (2011) Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial.Candesartan Antihypertensive Survival Evaluation in Japan（CASE-J）試験. Nihon Naika Gakkai Zasshi 100:5, pages 1449-1455.
Crossref
Kunihiro Matsushita, Takashi Muramatsu, Takahisa Kondo, Kengo Maeda, Satoshi Shintani & Toyoaki Murohara. (2010) Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance. Journal of Cardiology 56:1, pages 111-117.
Crossref
Helmy M. Siragy. (2010) Comparing angiotensin II receptor blockers on benefits beyond blood pressure. Advances in Therapy 27:5, pages 257-284.
Crossref
V V Fomin. (2009) Perspectives of using angiotensin receptor antagonists. Systemic Hypertension 6:2, pages 38-43.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.